Skip to content

Clinical trials

Glycogen Storage Disease Type II trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glycogen Storage Disease Type II Country / region: France Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20042
20053
20072
20091
20113
20131
20151
20181
20193
20201
20211
20221
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting4
Recruiting4
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genzyme, a Sanofi Company12
Amicus Therapeutics3
BioMarin Pharmaceutical2
Centre Hospitalier Universitaire de Nice2
Spark Therapeutics, Inc.2
Assistance Publique - Hôpitaux de Paris1
Assistance Publique Hopitaux De Marseille1
Astellas Gene Therapies1
Sanofi1
Shionogi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glycogen Storage Disease Type II26
Lysosomal Storage Diseases2
Glycogen Storage Disease1
Muscular Dystrophy, Duchenne1
Myotonia Congenita1
Rare Diseases1

Trials

Showing 76 to 26 of 26. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.